Related Experiment Video
Updated: Jun 15, 2026

07:45
Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
Published on: January 26, 2024
Lymph node drainage patterns and micrometastasis in lung cancer.
1Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA. anthony.kim@yale.edu
Seminars in Thoracic and Cardiovascular Surgery
|March 16, 2010
Summary
Lung cancer lymph node drainage patterns are consistent, but skip metastasis (25%) and micrometastasis (19%) require further investigation. Improved detection methods for micrometastatic disease are needed.
Area of Science:
- Oncology
- Surgical Pathology
- Thoracic Surgery
Background:
- Lymph node drainage patterns in lung cancer are well-established but evolving.
- Sentinel lymph node mapping and anatomic resections offer insights into lymphatic metastasis.
- Skip metastasis and micrometastasis remain areas of active research in lung cancer staging.
Purpose of the Study:
- To review historical and current understanding of lung cancer lymph node drainage patterns.
- To analyze the incidence and implications of skip metastasis and micrometastasis.
- To highlight the need for improved detection of micrometastatic disease.
Main Methods:
- Review of recent medical literature on lung cancer lymphatic drainage.
- Analysis of reported incidences of macroscopic skip metastasis and micrometastasis.
- Comparison of drainage patterns in skip versus non-skip metastases.
Main Results:
- Macroscopic skip metastasis occurs in approximately 25% of lung cancer cases.
- Micrometastasis is detected in approximately 19% of lung cancer cases.
- Drainage patterns for skip metastases are consistent with non-skip metastases to the mediastinum.
Conclusions:
- Generalized lymphatic drainage patterns are observed despite skip metastasis.
- Direct mediastinal drainage or detection limitations may explain skip metastasis.
- The similar incidence of skip metastasis and micrometastasis underscores the need for enhanced diagnostic capabilities.

